We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.65B
1-Year Est. Return 18.1%
This Fund
S&P 500
This Quarter Est. Return
+2.08%
1 Year Est. Return
+18.1%
3 Year Est. Return
+53.4%
5 Year Est. Return
+63.18%
10 Year Est. Return
+288.04%
AUM
$770M
AUM Growth
-$1.67M
Cap. Flow
-$10.2M
Cap. Flow %
-1.32%
Top 10 Hldgs %
20.83%
Holding
246
New
3
Increased
56
Reduced
119
Closed
5

Top Sells

Rank Stock Value
1
SRCL
Stericycle Inc
SRCL
+$2.14M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$1.42M
3
ATR icon
AptarGroup
ATR
+$1.2M
4
GILD icon
Gilead Sciences
GILD
+$1.12M
5
MIDD icon
Middleby
MIDD
+$1.06M

Sector Composition

Rank Sector Weight
1 Healthcare 17.46%
2 Industrials 14.26%
3 Miscellaneous 12.93%
4 Technology 12.61%
5 Consumer Staples 10.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RPM icon
76
RPM International
RPM
$12.9B
$3.14M 0.41%
58,273
-2,625
-4% -$134K
D icon
77
Dominion Energy
D
$56.7B
$3.02M 0.39%
39,495
MON
78
DELISTED
Monsanto Co
MON
$3M 0.39%
28,464
-1,100
-4% -$113K
NVS icon
79
Novartis
NVS
$264B
$2.87M 0.37%
43,924
DD
80
DELISTED
Du Pont De Nemours E I
DD
$2.85M 0.37%
38,899
-3,240
-8% -$230K
BMY icon
81
Bristol-Myers Squibb
BMY
$131B
$2.76M 0.36%
47,279
-9,460
-17% -$517K
DIS icon
82
Walt Disney
DIS
$188B
$2.73M 0.35%
26,197
-1,125
-4% -$110K
VEU icon
83
Vanguard FTSE All-World ex-US ETF
VEU
$69.4B
$2.72M 0.35%
61,609
-1,521
-2% -$67.4K
TEL icon
84
TE Connectivity
TEL
$58.9B
$2.67M 0.35%
38,489
-15
-0% -$994
TMO icon
85
Thermo Fisher Scientific
TMO
$227B
$2.66M 0.35%
18,865
+100
+0.5% +$14.7K
TEVA icon
86
Teva Pharmaceuticals
TEVA
$45.1B
$2.64M 0.34%
72,929
-35,590
-33% -$1.42M
APD icon
87
Air Products & Chemicals
APD
$63.9B
$2.58M 0.33%
17,911
-1,456
-8% -$204K
RTN
88
DELISTED
Raytheon Company
RTN
$2.5M 0.32%
17,611
+450
+3% +$63.9K
IWC icon
89
iShares Micro-Cap ETF
IWC
$1.44B
$2.48M 0.32%
28,945
-8,110
-22% -$651K
CLX icon
90
Clorox
CLX
$10.8B
$2.45M 0.32%
20,414
+2,400
+13% +$283K
EOG icon
91
EOG Resources
EOG
$77.9B
$2.44M 0.32%
24,180
+200
+0.8% +$19.5K
SHW icon
92
Sherwin-Williams
SHW
$78.5B
$2.39M 0.31%
26,652
-825
-3% -$72.9K
T icon
93
AT&T
T
$182B
$2.35M 0.31%
73,233
-585
-0.8% -$17.3K
HD icon
94
Home Depot
HD
$310B
$2.32M 0.3%
17,291
+215
+1% +$27.7K
FDX icon
95
FedEx
FDX
$74B
$2.23M 0.29%
11,949
AMGN icon
96
Amgen
AMGN
$206B
$2.19M 0.28%
14,950
-150
-1% -$22.6K
IDXX icon
97
Idexx Laboratories
IDXX
$40.1B
$2.18M 0.28%
18,580
-586
-3% -$66.9K
NEOG icon
98
Neogen
NEOG
$2.61B
$2.13M 0.28%
86,251
-466
-0.5% -$10.3K
APC
99
DELISTED
Anadarko Petroleum
APC
$2.05M 0.27%
29,463
QCOM icon
100
Qualcomm
QCOM
$192B
$2.04M 0.27%
31,348
-300
-0.9% -$20.2K

Similar funds

Boston Family Office's Q4 2016 Portfolio in Review

As of Q4 2016, Boston Family Office held 246 positions worth $770M, down 0.22% from $772M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Trading was light in Q4 2016: portfolio turnover was 3.3%. Boston Family Office opened 3 new positions and exited 5, leaving the 246-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Miscellaneous.

  • Boston Family Office's largest Q4 2016 buy was Juniper Networks: 11,000 shares worth $311K.
  • Boston Family Office added most to CVS Health in Q4 2016, an estimated $2.63M increase.
  • Boston Family Office's biggest Q4 2016 reduction was Stericycle Inc, cutting an estimated $2.14M.
  • Boston Family Office fully exited CF Industries in Q4 2016, selling an estimated $323K.
  • Boston Family Office's ten largest holdings make up 21% of its $770M portfolio in Q4 2016.
  • Boston Family Office opened 3 new positions and closed 5 in Q4 2016.
  • Boston Family Office's portfolio value fell 0.22% quarter-over-quarter to $770M.

Based on Boston Family Office's 13F filing for Q4 2016, filed 6 Feb 2017.